0% found this document useful (0 votes)
87 views3 pages

Dual Marker With Graph: Mrs G.Priya 8045132

The report for Mrs. G. Priya, a 21-year-old female, includes results from a dual marker test assessing the risk for Down syndrome and other conditions during the first trimester. The results indicate low risk for Down syndrome (T21) with a biochemical risk of 1:1076 and combined risk of 1:6437, as well as a low risk for Trisomy 13/18. Additional parameters such as Beta HCG and PAPP-A levels are provided, with recommendations for clinical correlation with other findings.

Uploaded by

Happy Moments
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
87 views3 pages

Dual Marker With Graph: Mrs G.Priya 8045132

The report for Mrs. G. Priya, a 21-year-old female, includes results from a dual marker test assessing the risk for Down syndrome and other conditions during the first trimester. The results indicate low risk for Down syndrome (T21) with a biochemical risk of 1:1076 and combined risk of 1:6437, as well as a low risk for Trisomy 13/18. Additional parameters such as Beta HCG and PAPP-A levels are provided, with recommendations for clinical correlation with other findings.

Uploaded by

Happy Moments
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd

Mrs G.

PRIYA APL Code : APL-AP-1706 Sample Type : SERUM


Age : 21 Year(s) Female Ref Doctor: G.SUJAYA SRI GARU MS SID : 8045132
OBS GYN
Collected on : 2025-08-14 10:10
Customer : SRI SRINIVASA LAB
█▐
█▐
█▐
▌▐█▐
▌▐█▐
▌▐█▐



▌▐█▐▌▐▌▐
▌▐█▐▌▐▌▐
▌▐█▐▌▐▌▐
█▌█▐█
█▌█▐█
█▌█▐█
▌▐
▌▐
▌▐
█▌▐▌█
█▌▐▌█
█▌▐▌█
▌█▌▐▌▐█
▌█▌▐▌▐█
▌█▌▐▌▐█
▌█
▌█
▌█



▌▐▌
▌▐▌
▌▐▌
█▌▌█
█▌▌█
█▌▌█
Regd on : 2025-08-14 12:36
█▐ ▌▐█▐ █ ▌▐█▐▌▐▌▐ █▌█▐█ ▌▐ █▌▐▌█ ▌█▌▐▌▐█ ▌█ ▌ ▌▐▌ █▌▌█
█▐ ▌▐█▐ █ ▌▐█▐▌▐▌▐ █▌█▐█ ▌▐ █▌▐▌█ ▌█▌▐▌▐█ ▌█ ▌ ▌▐▌ █▌▌█
█▐
█▐
▌▐█▐
▌▐█▐


▌▐█▐▌▐▌▐
▌▐█▐▌▐▌▐
█▌█▐█
█▌█▐█
▌▐
▌▐
█▌▐▌█
█▌▐▌█
▌█▌▐▌▐█
▌█▌▐▌▐█
▌█
▌█


▌▐▌
▌▐▌
█▌▌█
█▌▌█ Reported On : 2025-08-15 00:00

CLINICAL BIOCHEMISTRY
Test Description Result Units Biological Reference Ranges

DUAL MARKER with GRAPH


FIRST TRIMESTER RISK ESTIMATE

Down syndrome (T21) Biochemical Risk 1:1076 RiskCutoff Low Risk : > 1:250
High Risk : < 1:250
Down syndrome (T21) Combined Risk 1:6437 RiskCutoff Low Risk : > 1:250
High Risk : < 1:250
Down syndrome (T 21) Risk assessment Risk for Trisomy 21 (with nuchal translucency) is
below the cut off, which indicates a low risk.
Combined Trisomy 13/18 Risk Estimate <1:10000 RiskCutoff Low Risk : > 1:100
High Risk : < 1:100
Combined T13/18 Risk assessment Risk for trisomy 13/18 (with nuchal translucency) is <
1:10000, which represents a low risk.
Down syndrome(T21) Maternal Age Risk 1:1134

Beta Human Chorionic Gonodotropin Hormone 41.19 ng/mL < 2 : Non-Pregnant


(Free) 5.4 – 393.4 : Pregnant
MoM for Free Beta HCG 1.24

PAPP-A 5.43 mIU/mL < 0.1 : Non-Pregnant


0.1 – 19.5 : Pregnant
MoM for PAPP-A 0.55

Dr. SAI ABHISHEK VELPURI


Ch.Samuel
MD PATHOLOGIST
Manager Technical

This is an electronically authenticated report. Report printed date : 15/08/2025 16:59 Page 1 of 3
NOTE : Assay results should be correlated clinically with other clinical findings and the total clinical status of the patient.
Processed at Acclin Pathlabs India Pvt Ltd HYDERABAD Branch Report #
Mrs G.PRIYA APL Code : APL-AP-1706 Sample Type : SERUM
Age : 21 Year(s) Female Ref Doctor: G.SUJAYA SRI GARU MS SID : 8045132
OBS GYN
Collected on : 2025-08-14 10:10
Customer : SRI SRINIVASA LAB
█▐
█▐
█▐
▌▐█▐
▌▐█▐
▌▐█▐



▌▐█▐▌▐▌▐
▌▐█▐▌▐▌▐
▌▐█▐▌▐▌▐
█▌█▐█
█▌█▐█
█▌█▐█
▌▐
▌▐
▌▐
█▌▐▌█
█▌▐▌█
█▌▐▌█
▌█▌▐▌▐█
▌█▌▐▌▐█
▌█▌▐▌▐█
▌█
▌█
▌█



▌▐▌
▌▐▌
▌▐▌
█▌▌█
█▌▌█
█▌▌█
Regd on : 2025-08-14 12:36
█▐ ▌▐█▐ █ ▌▐█▐▌▐▌▐ █▌█▐█ ▌▐ █▌▐▌█ ▌█▌▐▌▐█ ▌█ ▌ ▌▐▌ █▌▌█
█▐ ▌▐█▐ █ ▌▐█▐▌▐▌▐ █▌█▐█ ▌▐ █▌▐▌█ ▌█▌▐▌▐█ ▌█ ▌ ▌▐▌ █▌▌█
█▐
█▐
▌▐█▐
▌▐█▐


▌▐█▐▌▐▌▐
▌▐█▐▌▐▌▐
█▌█▐█
█▌█▐█
▌▐
▌▐
█▌▐▌█
█▌▐▌█
▌█▌▐▌▐█
▌█▌▐▌▐█
▌█
▌█


▌▐▌
▌▐▌
█▌▌█
█▌▌█ Reported On : 2025-08-15 00:00

CLINICAL BIOCHEMISTRY
Test Description Result Units Biological Reference Ranges

Additional Information Interpretation provided in below table is only for


reference purpose and is not be used or depend on for
any diagnostic or treatment purpose and should not
be used as a alternative for professional diagnosis and
treatment.Please note that risk calculations are
statistical.

PATIENT DEMOGRAPHICS

Weight 41.6 Kgs

Date of birth 10.07.2005

H/O Diabetes Unknown

H/O IVF Unknown

Origin Asian

Date of scan 12.08.2025

No of fetus Single

Dr. SAI ABHISHEK VELPURI


Ch.Samuel
MD PATHOLOGIST
Manager Technical

This is an electronically authenticated report. Report printed date : 15/08/2025 16:59 Page 2 of 3
NOTE : Assay results should be correlated clinically with other clinical findings and the total clinical status of the patient.
Processed at Acclin Pathlabs India Pvt Ltd HYDERABAD Branch Report #
Mrs G.PRIYA APL Code : APL-AP-1706 Sample Type : SERUM
Age : 21 Year(s) Female Ref Doctor: G.SUJAYA SRI GARU MS SID : 8045132
OBS GYN
Collected on : 2025-08-14 10:10
Customer : SRI SRINIVASA LAB
█▐
█▐
█▐
▌▐█▐
▌▐█▐
▌▐█▐



▌▐█▐▌▐▌▐
▌▐█▐▌▐▌▐
▌▐█▐▌▐▌▐
█▌█▐█
█▌█▐█
█▌█▐█
▌▐
▌▐
▌▐
█▌▐▌█
█▌▐▌█
█▌▐▌█
▌█▌▐▌▐█
▌█▌▐▌▐█
▌█▌▐▌▐█
▌█
▌█
▌█



▌▐▌
▌▐▌
▌▐▌
█▌▌█
█▌▌█
█▌▌█
Regd on : 2025-08-14 12:36
█▐ ▌▐█▐ █ ▌▐█▐▌▐▌▐ █▌█▐█ ▌▐ █▌▐▌█ ▌█▌▐▌▐█ ▌█ ▌ ▌▐▌ █▌▌█
█▐ ▌▐█▐ █ ▌▐█▐▌▐▌▐ █▌█▐█ ▌▐ █▌▐▌█ ▌█▌▐▌▐█ ▌█ ▌ ▌▐▌ █▌▌█
█▐
█▐
▌▐█▐
▌▐█▐


▌▐█▐▌▐▌▐
▌▐█▐▌▐▌▐
█▌█▐█
█▌█▐█
▌▐
▌▐
█▌▐▌█
█▌▐▌█
▌█▌▐▌▐█
▌█▌▐▌▐█
▌█
▌█


▌▐▌
▌▐▌
█▌▌█
█▌▌█ Reported On : 2025-08-15 00:00

CLINICAL BIOCHEMISTRY
Test Description Result Units Biological Reference Ranges

MoM for NT 0.67

The interpretation of the results is achieved by considering the gestational age, smoking, in vitro
fertilization, diabetic status,no.of fetus and the medical history of the pregnant women. Complete
accurate information is required to produce the most accurate risk assessment possible for Trisomy 21
(Down syndrome), and Trisomy 18 (Edward Syndrome) for both First and second Trimester Screening.
Inaccurate or missing Information will lead to both false negative and false positive screens.

Dr. SAI ABHISHEK VELPURI


Ch.Samuel
MD PATHOLOGIST
Manager Technical

This is an electronically authenticated report. Report printed date : 15/08/2025 16:59 Page 3 of 3
NOTE : Assay results should be correlated clinically with other clinical findings and the total clinical status of the patient.
Processed at Acclin Pathlabs India Pvt Ltd HYDERABAD Branch Report #

You might also like